Detection windows · cannabinoid

THC (cannabis / marijuana) detection windows

THC is the principal psychoactive cannabinoid in cannabis. In workplace and clinical screening, the marker is THC-COOH (an inactive metabolite) — not THC itself — and its presence in urine does not reliably indicate recent use or impairment.

Last updated:

How long is THC (cannabis / marijuana) detectable?

Detection windows for THC (cannabis / marijuana) vary by specimen, use pattern, and individual factors. As approximate ranges: urine commonly covers a few days (longer in chronic users), oral fluid covers hours to about 48 hours, blood covers hours, and hair offers up to ~90 days after a ~7–10 day incorporation delay. Full matrix below — and see the interactive Explorer for cross-substance comparisons.

Approximate detection windows for THC (cannabis / marijuana)
Specimen Window Pattern Caveat
Urine 1–3 days occasional Single use; cutoff and hydration affect detection.
10–30 days chronic Daily, heavy use can extend to ~30 days or longer due to fat-soluble metabolite accumulation.
Saliva 1–24 hours typical Detects recent exposure (smoked/vaped); ingested edibles may shift the window.
Blood 1–12 hours occasional THC redistributes quickly; not a reliable indicator beyond same-day use in non-chronic users.
1–7 days chronic Residual THC and metabolites can persist longer in chronic, daily users.
Hair 7–90 days typical ~7–10 day incorporation delay; hair is not federally approved under SAMHSA/DOT and has documented bias concerns.

Ranges are approximate and vary by individual physiology, hydration, dose, frequency of use, and lab cutoff. They are not predictive of whether someone will "pass" a test.

About THC (cannabis / marijuana)

Δ9-Tetrahydrocannabinol (THC) is the primary psychoactive cannabinoid in Cannabis sativa. Drug tests target a lipid-soluble metabolite, 11-nor-9-carboxy-THC (THC-COOH), which is stored in body fat and excreted slowly — explaining the unusually long urine detection window in chronic users.

Key analytes / metabolites detected

  • THC-COOH (11-nor-9-carboxy-THC)
  • 11-OH-THC

Common cross-reactants (immunoassay-stage)

The following can affect screening immunoassay results and are typically resolved by mass-spectrometry confirmation and MRO review:

  • Some NSAIDs (rare, immunoassay-dependent)
  • Hemp / CBD products containing trace THC
  • Dronabinol (prescription)

Appears in panels

Confirmation method

GC-MS or LC-MS/MS is the standard confirmation method for THC (cannabis / marijuana).

Sources & references

drugtest.co content is sourced from primary regulatory and clinical references. We do not cite gray-market or "how to pass" sources.

  1. Mandatory Guidelines for Federal Workplace Drug Testing Programs (Urine) — SAMHSA
  2. Public Policy Statement on Drug Testing in Addiction Treatment — American Society of Addiction Medicine